title: STAT order: Should patients with chronic liver disease be prescribed statins to prevent fibrosis progression and hepatocellular carcinoma?
authors.affiliation: Cirrhosis Care Clinic, Division of Gastroenterology (Liver Unit), University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Juan G
authors.initials: JG
authors.lastname: Abraldes
authors.affiliation: Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
authors.forename: Kelly W
authors.initials: KW
authors.lastname: Burak
mesh_terms: D006528:Carcinoma, Hepatocellular; D018450:Disease Progression; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008103:Liver Cirrhosis; D008113:Liver Neoplasms
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors